AI assistant
EXELIXIS, INC. — Director's Dealing 2019
Nov 16, 2019
30561_dirs_2019-11-15_2b727c9a-cfeb-4f13-b8db-ceeb090a55dd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2019-11-15
Reporting Person: Schwab Gisela (Pres, Prod Dev & Med Aff & CMO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-11-15 | Common Stock | F | 9685 | $16.51 | Disposed | 316140 | Direct |
| 2019-11-15 | Common Stock | F | 2583 | $16.51 | Disposed | 313557 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 14880 | Indirect |
Footnotes
F1: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded October 3, 2017.
F2: Includes 47,698 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 888 and 606 shares of common stock acquired on April 30, 2019 and October 31, 2019, respectively, pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan.
F3: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded September 22, 2016.
F4: Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of November 14, 2019.